↓ Skip to main content

Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Overview of attention for article published in Radiation Oncology, August 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
29 Mendeley